Radiotherapy and Anrotinib in Malignant Glomus Tumor of the Bladder: A Case Report and Literature Review

Cancer Biother Radiopharm. 2024 May;39(4):318-321. doi: 10.1089/cbr.2023.0151. Epub 2024 Feb 7.

Abstract

Background: Malignant glomus tumors (MGTs) are rare malignancies, which grow rapidly and are aggressive. Surgical resection has been regarded as the standard management, but treatment options for those unresectable tumors are limited, resulting in a high recurrence rate and poor prognosis. Case Description: An 85-year-old man presented with gross hematuria and was diagnosed with MGTs of bladder. The patient achieved long-term local control after multimodal therapy comprising radiotherapy, iodine-125 seeds brachytherapy, transcatheter arterial chemoembolization, and antiangiogenic targeted therapy. Conclusion: MGTs occurring in the bladder are clinically rare and refractory. The case presented here highlights the importance of multidisciplinary diagnosis and treatment, providing evidence that radiotherapy and antiangiogenic therapy may play an important role in unresectable bladder MGT.

Keywords: antiangiogenic therapy; iodine-125 seed implantation; malignant glomus tumors; radiation therapy; transcatheter arterial chemoembolization.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged, 80 and over
  • Combined Modality Therapy / methods
  • Glomus Tumor* / pathology
  • Humans
  • Male
  • Urinary Bladder Neoplasms* / drug therapy
  • Urinary Bladder Neoplasms* / pathology
  • Urinary Bladder Neoplasms* / radiotherapy
  • Urinary Bladder Neoplasms* / therapy